OTUD6B and neoplasm: The tumor volumes and weights of xenografts treated with lncRNA OTUD6B-AS1 or As2O3 (5 mg/kg) were clearly reduced and much lower in those treated with both lncRNA OTUD6B-AS1 and As2O3 (all P < 0.01; Figures 2(a)–2(c)).